Literature DB >> 19040509

Rowell's syndrome in the course of treatment with sodium valproate: a case report and review of the literature data.

A Kacalak-Rzepka1, M Kiedrowicz, S Bielecka-Grzela, V Ratajczak-Stefanska, R Maleszka, D Mikulska.   

Abstract

Rowell's syndrome (RS) is a rare type of coexistence of one of the lupus erythematosus (LE) types (systemic, subacute cutaneous or discoid) and erythema multiforme (EM) (including toxic epidermal necrolysis). We present the case of a 51-year-old patient with a diagnosis of RS, most probably caused by drugs given as psychiatric treatment. After cessation of sodium valproate and initiation of treatment with prednisolone, a spectacular clinical remission was achieved. The likely role of psychiatric drugs, namely sodium valproate and sertraline, as triggering factors, is discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19040509     DOI: 10.1111/j.1365-2230.2008.02972.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  3 in total

1.  Rowell's syndrome induced by terbinafine.

Authors:  Aizuri Murad; Emma Shudell; Niall Mulligan
Journal:  BMJ Case Rep       Date:  2015-05-28

2.  Rowell's syndrome in an Indian male and review of the literature.

Authors:  Bhushan Madke; Uday Khopkar
Journal:  Indian Dermatol Online J       Date:  2015-12

3.  A Case of Rhupus with Rowell Syndrome.

Authors:  Abdulrahman Y Almansouri; Zeyad A Alzahrani
Journal:  Open Access Rheumatol       Date:  2020-06-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.